1-Ethyl-1H-3-nitrobenzopyrano[4,3,2-cd]isoindole: a novel heterocyclic ring system bearing an unusually labile deuterium-exchangeable aromatic proton

Tetrahedron Letters

Volumn 47, Issue 22, 2006, Pages 3681-3684

  Hadjipavlou, Christiana ^a   Kostakis, Ioannis K ^a   Pouli, Nicole ^a   Marakos, Panagiotis ^a   Mikros, Emmanuel ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Benzopyrano 4,3,2 cd isoindole; Proton deuterium exchange

Indexed keywords

1 ETHYL 1H 3 NITROBENZOPYRANO[4,3,2 CD]ISOINDOLE; AROMATIC COMPOUND; UNCLASSIFIED DRUG; XANTHENE DERIVATIVE;

ARTICLE; CALCULATION; DEUTERIUM HYDROGEN EXCHANGE; NUCLEAR MAGNETIC RESONANCE;

EID: 33646108110     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.03.130     Document Type: Article

References (23)

1. Pinto M.M., Sousa M.E., and Nascimento M.S. Curr. Med. Chem. 12 (2005) 2517-2538
2. Liu H.S., Lin C.N., and Won S.J. Anticancer Res. 17 (1997) 1107-1114
3. Zhou S., Kestell P., Baguley B.C., and Paxton J.W. Invest. New Drugs 20 (2002) 281-295
4. Ghosal S., Biswas K., and Chaudhuri R.K. J. Pharm. Sci. 67 (1978) 721-722
5. Hambloch H., Frahm A.W., and Wiedemann B. Eur. J. Med. Chem. 20 (1985) 71-77
6. Riscoe M., Kelly J.X., and Winter R. Curr. Med. Chem. 12 (2005) 2539-2549
7. Jiang D.J., Dai Z., and Li Y.J. Cardiovasc. Drug Rev. 22 (2004) 91-102
8. Kolokythas G., Kostakis I.K., Pouli N., Marakos P., Kletsas D., and Pratsinis H. Bioorg. Med. Chem. 11 (2003) 4591-4598
9. Kolokythas G., Kostakis I.K., Pouli N., Marakos P., Skaltsounis A.-L., and Pratsinis H. Bioorg. Med. Chem. Lett. 12 (2002) 1443-1446
10. Kostakis I.K., Magiatis P., Pouli N., Marakos P., Skaltsounis A.-L., Pratsinis H., Leonce S., and Pierre A. J. Med. Chem. 45 (2002) 2599-2609
11. Kostakis I.K., Tenta R., Pouli N., Marakos P., Skaltsounis A.-L., Pratsinis H., and Kletsas D. Bioorg. Med. Chem. Lett. 15 (2005) 5057-5060
12. Russkikh V.V., and Fokin E.P. J. Org. Chem. USSR (1982) 1385-1386
13. Gorelik M.V., and Alimova R.A. J. Org. Chem. USSR (1985) 1415-1422
14. Gorelik M.V., and Alimova R.A. J. Org. Chem. USSR (1984) 745-751
15. Pickert M., and Frahm A.W. Arch. Pharm. 311 (1998) 177-192
16. Recanatini M., Bisi A., Cavalli A., Belluti F., Gobbi S., Rampa A., Valentini P., Palzer M., Paluscazak A., and Hartmann R.W. J. Med. Chem. 44 (2001) 672-680
17. 2Br), 117.57 (C-5), 119.02 (C-9a), 120.30 (C-4), 122.79 (C-8a), 125.10 (C-7), 127.17 (C-8), 129.83 (C-3), 135.34 (C-6), 136.20 (C-1), 146.47 (C-2), 155.49 (C-4b), 159.65 (C-4a), 177.82 (CO).
18. 3. Calcd (%) C: 68.57, H: 4.32, N: 9.99. Found (%) C: 68.34, H: 4.23, N: 10.17.
19. Junk T., and Catallo W.J. Chem. Soc. Rev. 26 (1997) 401-406
20. Rosku S., Wähälä K., Koskimies J., and Hase T. Tetrahedron 55 (1999) 3445-3454
21. Boix C., and Poliakoff M. Tetrahedron Lett. 40 (1999) 4433-4436
22. -1, using the Polak-Ribiere (conjugate gradient) geometry optimization method as implemented in the HyperChem 5.0 software (Hypercube Inc).
23. Allen F.H., Baalham C.A., Lommerse J.P.M., Raithby P.R., and Sparr E. Acta Crystallogr. Sect. B: Struct. Sci. 53 (1997) 1017-1024